BubR1 is involved in regulation of DNA damage responses
Defective mitotic spindles or an impaired spindle-kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1 haplo-insufficiency results in enhanced genomic instability and tumorigenesis in mice. Here we report that BubR1 deficiency also leads to a compromised resp...
Saved in:
Published in | Oncogene Vol. 25; no. 25; pp. 3598 - 3605 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Basingstoke
Nature Publishing
15.06.2006
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Defective mitotic spindles or an impaired spindle-kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1 haplo-insufficiency results in enhanced genomic instability and tumorigenesis in mice. Here we report that BubR1 deficiency also leads to a compromised response to DNA damage. Following treatment with doxorubicin, BubR1(+/-) murine fibroblast cells (MEF) were defective in undergoing G(2)/M arrest. Thus, whereas in the presence of DNA damage BubR1(+/+) MEF cells remained arrested in mitosis, BubR1(+/-) MEFs rapidly exited from mitosis and divided. The impaired mitotic arrest of BubR1(+/-) MEFs was associated with low levels of phospho-histone H2AX, p53, and p21 after DNA damage caused by treatment with both doxorubicin and ultraviolet light (UV). The impaired expression of p53 and p21 was also confirmed in human cell lines with BubR1 knockdown via RNA interference. Affinity pull-down coupled with mass spectrometry identified Poly(ADP-ribose) polymerase 1 (PARP-1) as one of the proteins interacting with BubR1. Reciprocal co-immunoprecipitation analysis confirmed the physical interaction between BubR1 and PARP-1. Our further study revealed that the ability of retaining intact PARP-1 or its cleavage product p89 was compromised in BubR1(+/-) MEFs upon treatment with doxorubicin or UV. Given that PARP-1 mediates DNA damage responses and regulates the activity of p53, our studies suggest that there exists a cross-talk between the spindle checkpoint and the DNA damage checkpoint and that BubR1 may play an important role in mediating the cross-talk. |
---|---|
AbstractList | Defective mitotic spindles or an impaired spindle-kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1 haplo- insufficiency results in enhanced genomic instability and tumorigenesis in mice. Here we report that BubR1 deficiency also leads to a compromised response to DNA damage. Following treatment with doxorubicin, BubR1 super(+/-) murine fibroblast cells (MEF) were defective in undergoing G sub(2)/M arrest. Thus, whereas in the presence of DNA damage BubR1 super(+/+) MEF cells remained arrested in mitosis, BubR1 super(+/-) MEFs rapidly exited from mitosis and divided. The impaired mitotic arrest of BubR1 super(+/-) MEFs was associated with low levels of phospho-histone H2AX, p53, and p21 after DNA damage caused by treatment with both doxorubicin and ultraviolet light (UV). The impaired expression of p53 and p21 was also confirmed in human cell lines with BubR1 knockdown via RNA interference. Affinity pull-down coupled with mass spectrometry identified Poly(ADP-ribose) polymerase 1 (PARP-1) as one of the proteins interacting with BubR1. Reciprocal co-immunoprecipitation analysis confirmed the physical interaction between BubR1 and PARP-1. Our further study revealed that the ability of retaining intact PARP-1 or its cleavage product p89 was compromised in BubR1 super(+/-) MEFs upon treatment with doxorubicin or UV. Given that PARP-1 mediates DNA damage responses and regulates the activity of p53, our studies suggest that there exists a cross-talk between the spindle checkpoint and the DNA damage checkpoint and that BubR1 may play an important role in mediating the cross-talk. Defective mitotic spindles or an impaired spindle-kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1 haplo-insufficiency results in enhanced genomic instability and tumorigenesis in mice. Here we report that BubR1 deficiency also leads to a compromised response to DNA damage. Following treatment with doxorubicin, BubR1 super(+/-) murine fibroblast cells (MEF) were defective in undergoing G sub(2)/M arrest. Thus, whereas in the presence of DNA damage BubR1 super(+/+) MEF cells remained arrested in mitosis, BubR1 super(+/-) MEFs rapidly exited from mitosis and divided. The impaired mitotic arrest of BubR1 super(+/-) MEFs was associated with low levels of phospho-histone H2AX, p53, and p21 after DNA damage caused by treatment with both doxorubicin and ultraviolet light (UV). The impaired expression of p53 and p21 was also confirmed in human cell lines with BubR1 knockdown via RNA interference. Affinity pull-down coupled with mass spectrometry identified Poly(ADP-ribose) polymerase 1 (PARP-1) as one of the proteins interacting with BubR1. Reciprocal co-immunoprecipitation analysis confirmed the physical interaction between BubR1 and PARP-1. Our further study revealed that the ability of retaining intact PARP-1 or its cleavage product p89 was compromised in BubR1 super(+/-) MEFs upon treatment with doxorubicin or UV. Given that PARP-1 mediates DNA damage responses and regulates the activity of p53, our studies suggest that there exists a cross-talk between the spindle checkpoint and the DNA damage checkpoint and that BubR1 may play an important role in mediating the cross-talk.Oncogene (2006) 25, 3598-3605. doi:10.1038/sj.onc.1209392; published online 30 January 2006 Defective mitotic spindles or an impaired spindle-kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1 haplo-insufficiency results in enhanced genomic instability and tumorigenesis in mice. Here we report that BubR1 deficiency also leads to a compromised response to DNA damage. Following treatment with doxorubicin, BubR1(+/-) murine fibroblast cells (MEF) were defective in undergoing G(2)/M arrest. Thus, whereas in the presence of DNA damage BubR1(+/+) MEF cells remained arrested in mitosis, BubR1(+/-) MEFs rapidly exited from mitosis and divided. The impaired mitotic arrest of BubR1(+/-) MEFs was associated with low levels of phospho-histone H2AX, p53, and p21 after DNA damage caused by treatment with both doxorubicin and ultraviolet light (UV). The impaired expression of p53 and p21 was also confirmed in human cell lines with BubR1 knockdown via RNA interference. Affinity pull-down coupled with mass spectrometry identified Poly(ADP-ribose) polymerase 1 (PARP-1) as one of the proteins interacting with BubR1. Reciprocal co-immunoprecipitation analysis confirmed the physical interaction between BubR1 and PARP-1. Our further study revealed that the ability of retaining intact PARP-1 or its cleavage product p89 was compromised in BubR1(+/-) MEFs upon treatment with doxorubicin or UV. Given that PARP-1 mediates DNA damage responses and regulates the activity of p53, our studies suggest that there exists a cross-talk between the spindle checkpoint and the DNA damage checkpoint and that BubR1 may play an important role in mediating the cross-talk. Defective mitotic spindles or an impaired spindle–kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1 haplo-insufficiency results in enhanced genomic instability and tumorigenesis in mice. Here we report that BubR1 deficiency also leads to a compromised response to DNA damage. Following treatment with doxorubicin, BubR1+/− murine fibroblast cells (MEF) were defective in undergoing G2/M arrest. Thus, whereas in the presence of DNA damage BubR1+/+ MEF cells remained arrested in mitosis, BubR1+/− MEFs rapidly exited from mitosis and divided. The impaired mitotic arrest of BubR1+/− MEFs was associated with low levels of phospho-histone H2AX, p53, and p21 after DNA damage caused by treatment with both doxorubicin and ultraviolet light (UV). The impaired expression of p53 and p21 was also confirmed in human cell lines with BubR1 knockdown via RNA interference. Affinity pull-down coupled with mass spectrometry identified Poly(ADP-ribose) polymerase 1 (PARP-1) as one of the proteins interacting with BubR1. Reciprocal co-immunoprecipitation analysis confirmed the physical interaction between BubR1 and PARP-1. Our further study revealed that the ability of retaining intact PARP-1 or its cleavage product p89 was compromised in BubR1+/− MEFs upon treatment with doxorubicin or UV. Given that PARP-1 mediates DNA damage responses and regulates the activity of p53, our studies suggest that there exists a cross-talk between the spindle checkpoint and the DNA damage checkpoint and that BubR1 may play an important role in mediating the cross-talk. |
Audience | Academic |
Author | DARZYNKIEWICZ, Z LIU, T WANG, X YANG, Y.-M DENG, H DAI, W LU, L FANG, Y KUNICKI, J TRAGANOS, F |
Author_xml | – sequence: 1 givenname: Y surname: FANG fullname: FANG, Y organization: Division of Molecular Carcinogenesis, New York Medical College, Valhalla, NY 10595, United States – sequence: 2 givenname: T surname: LIU fullname: LIU, T organization: Division of Molecular Carcinogenesis, New York Medical College, Valhalla, NY 10595, United States – sequence: 3 givenname: X surname: WANG fullname: WANG, X organization: Division of Molecular Carcinogenesis, New York Medical College, Valhalla, NY 10595, United States – sequence: 4 givenname: Y.-M surname: YANG fullname: YANG, Y.-M organization: Division of Molecular Carcinogenesis, New York Medical College, Valhalla, NY 10595, United States – sequence: 5 givenname: H surname: DENG fullname: DENG, H organization: Proteomics Core Facility, Rockefeller University, New York, NY 10021, United States – sequence: 6 givenname: J surname: KUNICKI fullname: KUNICKI, J organization: Department of Medicine, New York Medical College, Valhalla, NY 10595, United States – sequence: 7 givenname: F surname: TRAGANOS fullname: TRAGANOS, F organization: Department of Medicine, New York Medical College, Valhalla, NY 10595, United States – sequence: 8 givenname: Z surname: DARZYNKIEWICZ fullname: DARZYNKIEWICZ, Z organization: Grander Cancer Institute, New York Medical College, Valhalla, NY 10595, United States – sequence: 9 givenname: L surname: LU fullname: LU, L organization: Division of Molecular Medicine, Harbor-UCLA Medical Center, University of California Los Angeles, Torrance, CA 90502, United States – sequence: 10 givenname: W surname: DAI fullname: DAI, W organization: Division of Molecular Carcinogenesis, New York Medical College, Valhalla, NY 10595, United States |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17863475$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16449973$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkd1rFDEUxYO02G311TdlqLRvs-Y7k8e1VlsoCqLPIZO5WWaZSdZkpuB_b5YOLEhF7kMuN79zT8I5RychBkDoDcFrglnzIe_WMbg1oVgzTV-gFeFK1kJofoJWWAtca8roGTrPeYcxVhrTl-iMSM61VmyF1Me5_U6qPld9eIzDI3SlqRJs58FOfQxV9NWnr5uqs6PdQrnI-xgy5Ffo1Nshw-vlvEA_P9_-uLmrH759ub_ZPNROSD3VnSQWN56D81ZYxqVotZNtq7SwjQfFLeGuzAlh3rWSUw-aAEiJi671DbtA10979yn-miFPZuyzg2GwAeKcDSWMYaLk_0GsWCOoKOD7v8BdnFMonzBUcsIKQ3GhLv9JUcVEgxtyXLW1A5g--Dgl6w6-ZkMajYWk8mC4foYq1cHYuxKn78v8OYFLMecE3uxTP9r02xBsDqmbvDMldbOkXgTvlsfO7QjdEV9iLsDVAtjs7OCTDa7PR041knF1cH77xAU7zQmOwGL0B6-NvJs |
CODEN | ONCNES |
CitedBy_id | crossref_primary_10_1016_j_tig_2019_01_003 crossref_primary_10_1016_j_virol_2010_02_003 crossref_primary_10_1074_jbc_M608406200 crossref_primary_10_1007_s12032_013_0526_7 crossref_primary_10_1016_j_devcel_2016_10_023 crossref_primary_10_1016_j_molmed_2015_04_003 crossref_primary_10_1016_j_molcel_2015_03_034 crossref_primary_10_4161_cc_28419 crossref_primary_10_1038_ncb2643 crossref_primary_10_1016_j_ceb_2006_10_002 crossref_primary_10_1534_g3_117_1122 crossref_primary_10_1016_j_febslet_2006_03_081 crossref_primary_10_1158_1541_7786_MCR_06_0395 crossref_primary_10_1038_nrc2781 crossref_primary_10_1586_epr_11_63 crossref_primary_10_1136_jcp_2006_044305 crossref_primary_10_1534_g3_111_000265 crossref_primary_10_1093_hmg_ddaa076 crossref_primary_10_1016_j_clon_2008_06_010 crossref_primary_10_1002_ijc_31718 crossref_primary_10_1016_j_febslet_2011_05_013 crossref_primary_10_1016_j_chemosphere_2020_128994 crossref_primary_10_1186_s13008_015_0009_7 crossref_primary_10_1158_0008_5472_CAN_07_2266 crossref_primary_10_1002_hed_21342 crossref_primary_10_1155_2012_195903 crossref_primary_10_1128_JVI_01515_08 crossref_primary_10_1016_j_biocel_2009_11_011 crossref_primary_10_1038_s41388_021_02021_y crossref_primary_10_18632_oncotarget_6432 crossref_primary_10_1016_j_ccr_2006_12_003 crossref_primary_10_1038_nrm1963 crossref_primary_10_1038_onc_2010_53 crossref_primary_10_1016_j_bbamcr_2008_08_006 crossref_primary_10_1016_j_tcb_2008_03_003 crossref_primary_10_1128_MCB_00310_06 crossref_primary_10_3389_fcell_2021_700162 crossref_primary_10_1021_acs_jmedchem_3c00963 crossref_primary_10_1038_bjc_2013_189 crossref_primary_10_1016_j_bbcan_2008_04_001 crossref_primary_10_1016_j_redox_2023_102701 crossref_primary_10_1371_journal_pgen_1000015 crossref_primary_10_4161_cc_24403 crossref_primary_10_1371_journal_pgen_1005150 crossref_primary_10_1016_j_bbrc_2007_04_125 crossref_primary_10_1016_j_dnarep_2011_10_018 crossref_primary_10_1016_j_yexcr_2019_01_013 crossref_primary_10_1016_j_semcdb_2013_02_001 crossref_primary_10_1002_mc_20412 crossref_primary_10_1186_1747_1028_5_13 crossref_primary_10_1016_j_molcel_2015_11_006 |
Cites_doi | 10.1074/jbc.M211641200 10.1038/sj.onc.1207374 10.1016/S0959-437X(02)00282-4 10.1038/35023629 10.1093/emboj/cdg206 10.1038/32688 10.1038/ng997 10.1038/nature03061 10.1191/0267659103pf684oa 10.1146/annurev.biochem.73.011303.073723 10.1038/sj.onc.1207411 10.1074/jbc.M203793200 10.1038/sj.onc.1208218 10.1073/pnas.0407822102 10.1016/S0092-8674(03)00755-4 10.1038/35044005 10.1038/nature02330 10.1074/jbc.272.45.28646 10.1038/25292 10.1038/sj.onc.1207873 10.1074/jbc.M007269200 10.1038/ng1449 10.1126/science.1084468 10.1128/MCB.22.10.3450-3459.2002 10.1146/annurev.genet.37.042203.120656 10.1074/jbc.M200620200 10.1016/j.dnarep.2004.06.002 10.1158/0008-5472.CAN-03-3119 10.1016/j.cell.2004.12.002 10.1016/S0960-9822(02)01226-5 |
ContentType | Journal Article |
Copyright | 2006 INIST-CNRS COPYRIGHT 2006 Nature Publishing Group Copyright Nature Publishing Group Jun 15, 2006 Nature Publishing Group 2006. |
Copyright_xml | – notice: 2006 INIST-CNRS – notice: COPYRIGHT 2006 Nature Publishing Group – notice: Copyright Nature Publishing Group Jun 15, 2006 – notice: Nature Publishing Group 2006. |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7TM 7TO 7U9 7X7 7XB 88A 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. LK8 M0S M1P M2O M7P MBDVC P64 PQEST PQQKQ PQUKI PRINS Q9U RC3 |
DOI | 10.1038/sj.onc.1209392 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts ProQuest_Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database (Proquest) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest research library Biological Science Database Research Library (Corporate) Biotechnology and BioEngineering Abstracts ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Genetics Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts Technology Research Database ProQuest Central Essentials Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | Genetics Abstracts Genetics Abstracts Research Library Prep Research Library Prep MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Biology |
EISSN | 1476-5594 |
EndPage | 3605 |
ExternalDocumentID | 1060736401 A189056265 10_1038_sj_onc_1209392 16449973 17863475 1209392 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: R01 CA028704-27 – fundername: NCI NIH HHS grantid: R01 CA028704 – fundername: NCI NIH HHS grantid: R01-CA90658 |
GroupedDBID | - -Q- 0R 123 29N 2WC 39C 3O- 3V. 4.4 53G 55 5RE 7X7 88A 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AADWK AAPBV AAWBL AAYJO AAZLF ABAWZ ABDBF ABDEU ABFLS ABGIJ ABPTK ABUWG ACGFS ACKTT ACPRK ADBBV ADBIT ADHDB ADQMX AEDAW AEJRE AENEX AEXYK AFKRA AFSHS AGEZK AHMBA AHSBF AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AXYYD AZFZN AZQEC B0M BBAFP BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG COF CS3 DIK DU5 DWQXO E3Z EAD EAP EBC EBD EBLON EBS EE. EIOEI EJD EMB EMK EPL ESX F5P FDQFY FEDTE FERAY FIZPM FRP FSGXE FYUFA GNUQQ GUQSH HCIFZ HVGLF HZ IAO IHR INH INR ITC JSO KQ8 L7B LK8 M0L M1P M2O M7P N9A NAO O9- OK1 OVD P2P PADUT PQEST PQQKQ PQUKI PRINS PROAC PSQYO Q- Q2X RIG RNS RNT RNTTT SNX SNYQT SV3 SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG TUS UDS W2D WH7 X7M ZA5 --- .55 .GJ 08R 0R~ 36B 406 70F AANZL AATNV AAUGY AAYFA ABEFU ABLJU ACBMV ACBRV ACBYP ACGFO ACIGE ACMJI ACRQY ACTTH ACVWB ADFRT ADMDM ADYYL AEFTE AEVLU AFFNX AFNRJ AGGBP AGHAI AILAN AJCLW AJDOV AMRJV AMYLF BAWUL CCPQU DNIVK DPUIP EMOBN HZ~ IQODW IWAJR JZLTJ NQJWS NXXTH NYICJ SOHCF SRMVM UKHRP ZXP ~8M AAYZH ABAKF ABJNI ABZZP ACAOD ACZOJ AEMSY AFBBN AGQEE ALIPV CGR CUY CVF ECM EIF HMCUK NPM AAYXX CITATION AHPSJ FIGPU 7TM 7TO 7U9 7XB 8FD 8FK FR3 H94 K9. MBDVC P64 Q9U RC3 |
ID | FETCH-LOGICAL-c569t-d61a08f4ecfa5a3465b9c6bb795a8fe74a14ca34113fcb642fe91ee6601a0bf83 |
IEDL.DBID | BENPR |
ISSN | 0950-9232 |
IngestDate | Sat Oct 26 01:38:02 EDT 2024 Fri Oct 25 11:49:09 EDT 2024 Wed Nov 06 07:46:47 EST 2024 Thu Oct 10 19:36:21 EDT 2024 Fri Feb 23 00:21:48 EST 2024 Tue Nov 12 23:43:40 EST 2024 Fri Sep 27 02:37:03 EDT 2024 Tue Oct 15 23:30:47 EDT 2024 Sun Oct 22 16:03:39 EDT 2023 Thu Oct 07 19:41:30 EDT 2021 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 25 |
Keywords | Regulation(control) TP53 Gene BuhR1: DNA damage: checkpoint: p53 DNA Cell cycle CDKN1A Gene PARP Lesion Carcinogenesis Control point p21 Tumor suppressor gene |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c569t-d61a08f4ecfa5a3465b9c6bb795a8fe74a14ca34113fcb642fe91ee6601a0bf83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://dx.doi.org/10.1038/sj.onc.1209392 |
PMID | 16449973 |
PQID | 227358081 |
PQPubID | 36330 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_21330176 proquest_miscellaneous_20738525 proquest_journals_2641352520 proquest_journals_227358081 gale_infotracmisc_A189056265 gale_infotracacademiconefile_A189056265 crossref_primary_10_1038_sj_onc_1209392 pubmed_primary_16449973 pascalfrancis_primary_17863475 nature_primary_1209392 |
ProviderPackageCode | ABDEU AEDAW AAZLF -Q- AADWK AAYJO ADQMX EE. RNTTT SWTZT ABGIJ RNT NAO |
PublicationCentury | 2000 |
PublicationDate | 2006-06-15 |
PublicationDateYYYYMMDD | 2006-06-15 |
PublicationDate_xml | – month: 06 year: 2006 text: 2006-06-15 day: 15 |
PublicationDecade | 2000 |
PublicationPlace | Basingstoke |
PublicationPlace_xml | – name: Basingstoke – name: England – name: New York |
PublicationTitle | Oncogene |
PublicationTitleAlternate | Oncogene |
PublicationYear | 2006 |
Publisher | Nature Publishing Nature Publishing Group |
Publisher_xml | – name: Nature Publishing – name: Nature Publishing Group |
References | Rao, CV, Yang, M, Malisetty, S, Liu, T-Y, Fang, Y-Q, Mahmood, R 2005; 102 Wang, Q, Xie, S, Chen, J, Fukasawa, K, Naik, U, Traganos, F 2002; 22 Xie, S, Xie, B, Lee, MY, Dai, W 2005; 24 Cahill, DP, Lengauer, C, Yu, J, Riggins, GJ, Willson, JK, Markowitz, SD 1998; 392 Yang, Y, Li, CC, Weissman, AM 2004; 23 Chang, P, Jacobson, MK, Mitchison, TJ 2004; 432 Hanks, S, Coleman, K, Reid, S, Plaja, A, Firth, H, Fitzpatrick, D 2004; 36 Affar, EB, Germain, M, Winstall, E, Vodenicharov, M, Shah, RG, Salvesen, GS 2001; 276 Lew, DJ, Burke, DJ 2003; 37 Bashir, T, Dorrello, NV, Amador, V, Guardavaccaro, D, Pagano, M 2004; 428 Huber, A, Bai, P, de Murcia, JM, de Murcia, G 2004; 3 Hamid, T, Kakar, SS 2003; 18 Lengauer, C, Kinzler, KW, Vogelstein, B 1998; 396 Ouyang, B, Pan, H, Lu, L, Li, J, Stambrook, P, Li, B 1997; 272 Wieler, S, Gagne, JP, Vaziri, H, Poirier, GG, Benchimol, S 2003; 278 Nitta, M, Kobayashi, O, Honda, S, Hirota, T, Kuninaka, S, Marumoto, T 2004; 23 Smits, VA, Klompmaker, R, Arnaud, L, Rijksen, G, Nigg, EA, Medema, RH 2000; 2 Pirrotta, V 2004; 119 Bernal, JA, Luna, R, Espina, A, Lazaro, I, Ramos-Morales, F, Romero, F 2002; 32 Lengauer, C 2003; 300 Li, W, Lan, Z, Wu, H, Wu, S, Meadows, J, Chen, J 1999; 10 Saxena, A, Saffery, R, Wong, LH, Kalitsis, P, Choo, KH 2002; 277 Zhou, BB, Elledge, SJ 2000; 408 Redon, C, Pilch, D, Rogakou, E, Sedelnikova, O, Newrock, K, Bonner, W 2002; 12 Bloom, J, Amador, V, Bartolini, F, DeMartino, G, Pagano, M 2003; 115 Sancar, A, Lindsey-Boltz, LA, Unsal-Kacmaz, K, Linn, S 2004; 73 Bharadwaj, R, Yu, H 2004; 23 Mikhailov, A, Cole, RW, Rieder, CL 2002; 12 Zhou, Y, Mehta, KR, Choi, AP, Scolavino, S, Zhang, X 2003; 278 Menissier, dM, Ricoul, M, Tartier, L, Niedergang, C, Huber, A, Dantzer, F 2003; 22 Dai, W, Wang, Q, Liu, T-Y, Swamy, M, Fang, Y-Q, Xie, S-Q 2004; 15 BF1209392_CR25 BF1209392_CR24 BF1209392_CR23 BF1209392_CR22 BF1209392_CR29 BF1209392_CR28 BF1209392_CR27 BF1209392_CR26 BF1209392_CR21 BF1209392_CR20 BF1209392_CR19 BF1209392_CR14 BF1209392_CR13 BF1209392_CR12 BF1209392_CR11 BF1209392_CR18 BF1209392_CR17 BF1209392_CR16 BF1209392_CR15 BF1209392_CR10 BF1209392_CR31 BF1209392_CR9 BF1209392_CR30 BF1209392_CR8 BF1209392_CR7 BF1209392_CR6 BF1209392_CR5 BF1209392_CR4 BF1209392_CR3 BF1209392_CR2 BF1209392_CR1 |
References_xml | – volume: 2 start-page: 672 year: 2000 end-page: 676 publication-title: Nat Cell Biol contributor: fullname: Medema, RH – volume: 23 start-page: 2016 year: 2004 end-page: 2027 publication-title: Oncogene contributor: fullname: Yu, H – volume: 12 start-page: 1797 year: 2002 end-page: 1806 publication-title: Curr Biol contributor: fullname: Rieder, CL – volume: 10 start-page: 769 year: 1999 end-page: 775 publication-title: Cell Growth Differ contributor: fullname: Chen, J – volume: 3 start-page: 1103 year: 2004 end-page: 1108 publication-title: DNA Repair (Amsterdam) contributor: fullname: de Murcia, G – volume: 15 start-page: 440 year: 2004 end-page: 445 publication-title: Cancer Res contributor: fullname: Xie, S-Q – volume: 18 start-page: 245 year: 2003 end-page: 251 publication-title: Histol Histopathol contributor: fullname: Kakar, SS – volume: 428 start-page: 190 year: 2004 end-page: 193 publication-title: Nature contributor: fullname: Pagano, M – volume: 392 start-page: 300 year: 1998 end-page: 303 publication-title: Nature contributor: fullname: Markowitz, SD – volume: 22 start-page: 2255 year: 2003 end-page: 2263 publication-title: EMBO J contributor: fullname: Dantzer, F – volume: 408 start-page: 433 year: 2000 end-page: 439 publication-title: Nature contributor: fullname: Elledge, SJ – volume: 432 start-page: 645 year: 2004 end-page: 649 publication-title: Nature contributor: fullname: Mitchison, TJ – volume: 272 start-page: 28646 year: 1997 end-page: 28651 publication-title: J Biol Chem contributor: fullname: Li, B – volume: 37 start-page: 251 year: 2003 end-page: 282 publication-title: Annu Rev Genet contributor: fullname: Burke, DJ – volume: 73 start-page: 39 year: 2004 end-page: 85 publication-title: Annu Rev Biochem contributor: fullname: Linn, S – volume: 12 start-page: 162 year: 2002 end-page: 169 publication-title: Curr Opin Genet Dev contributor: fullname: Bonner, W – volume: 24 start-page: 277 year: 2005 end-page: 286 publication-title: Oncogene contributor: fullname: Dai, W – volume: 396 start-page: 643 year: 1998 end-page: 649 publication-title: Nature contributor: fullname: Vogelstein, B – volume: 119 start-page: 735 year: 2004 end-page: 736 publication-title: Cell contributor: fullname: Pirrotta, V – volume: 115 start-page: 71 year: 2003 end-page: 82 publication-title: Cell contributor: fullname: Pagano, M – volume: 23 start-page: 6548 year: 2004 end-page: 6558 publication-title: Oncogene contributor: fullname: Marumoto, T – volume: 278 start-page: 18914 year: 2003 end-page: 18921 publication-title: J Biol Chem contributor: fullname: Benchimol, S – volume: 278 start-page: 462 year: 2003 end-page: 470 publication-title: J Biol Chem contributor: fullname: Zhang, X – volume: 32 start-page: 306 year: 2002 end-page: 311 publication-title: Nat Genet contributor: fullname: Romero, F – volume: 23 start-page: 2096 year: 2004 end-page: 2106 publication-title: Oncogene contributor: fullname: Weissman, AM – volume: 22 start-page: 3450 year: 2002 end-page: 3459 publication-title: Mol Cell Biol contributor: fullname: Traganos, F – volume: 36 start-page: 1159 year: 2004 end-page: 1161 publication-title: Nat Genet contributor: fullname: Fitzpatrick, D – volume: 300 start-page: 442 year: 2003 end-page: 443 publication-title: Science contributor: fullname: Lengauer, C – volume: 102 start-page: 4365 year: 2005 end-page: 4370 publication-title: Proc Natl Acad Sci USA contributor: fullname: Mahmood, R – volume: 277 start-page: 26921 year: 2002 end-page: 26926 publication-title: J Biol Chem contributor: fullname: Choo, KH – volume: 276 start-page: 2935 year: 2001 end-page: 2942 publication-title: J Biol Chem contributor: fullname: Salvesen, GS – ident: BF1209392_CR27 doi: 10.1074/jbc.M211641200 – ident: BF1209392_CR4 doi: 10.1038/sj.onc.1207374 – ident: BF1209392_CR22 doi: 10.1016/S0959-437X(02)00282-4 – ident: BF1209392_CR25 doi: 10.1038/35023629 – ident: BF1209392_CR16 doi: 10.1093/emboj/cdg206 – ident: BF1209392_CR6 doi: 10.1038/32688 – ident: BF1209392_CR3 doi: 10.1038/ng997 – ident: BF1209392_CR7 doi: 10.1038/nature03061 – ident: BF1209392_CR9 doi: 10.1191/0267659103pf684oa – ident: BF1209392_CR23 doi: 10.1146/annurev.biochem.73.011303.073723 – ident: BF1209392_CR29 doi: 10.1038/sj.onc.1207411 – ident: BF1209392_CR31 doi: 10.1074/jbc.M203793200 – ident: BF1209392_CR28 doi: 10.1038/sj.onc.1208218 – ident: BF1209392_CR21 doi: 10.1073/pnas.0407822102 – ident: BF1209392_CR5 doi: 10.1016/S0092-8674(03)00755-4 – ident: BF1209392_CR15 – ident: BF1209392_CR30 doi: 10.1038/35044005 – ident: BF1209392_CR2 doi: 10.1038/nature02330 – ident: BF1209392_CR19 doi: 10.1074/jbc.272.45.28646 – ident: BF1209392_CR13 doi: 10.1038/25292 – ident: BF1209392_CR18 doi: 10.1038/sj.onc.1207873 – ident: BF1209392_CR1 doi: 10.1074/jbc.M007269200 – ident: BF1209392_CR10 doi: 10.1038/ng1449 – ident: BF1209392_CR12 doi: 10.1126/science.1084468 – ident: BF1209392_CR26 doi: 10.1128/MCB.22.10.3450-3459.2002 – ident: BF1209392_CR14 doi: 10.1146/annurev.genet.37.042203.120656 – ident: BF1209392_CR24 doi: 10.1074/jbc.M200620200 – ident: BF1209392_CR11 doi: 10.1016/j.dnarep.2004.06.002 – ident: BF1209392_CR8 doi: 10.1158/0008-5472.CAN-03-3119 – ident: BF1209392_CR20 doi: 10.1016/j.cell.2004.12.002 – ident: BF1209392_CR17 doi: 10.1016/S0960-9822(02)01226-5 |
SSID | ssj0007902 |
Score | 2.1728175 |
Snippet | Defective mitotic spindles or an impaired spindle-kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1... Defective mitotic spindles or an impaired spindle–kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1... Defective mitotic spindles or an impaired spindle-kinetochore interaction activates the spindle checkpoint. We have previously shown that BubR1 haplo-... |
SourceID | proquest gale crossref pubmed pascalfrancis nature |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 3598 |
SubjectTerms | Animals Antibiotics, Antineoplastic - toxicity Biological and medical sciences Blotting, Western BUBR1 protein Cell Cycle Proteins Cell cycle, cell proliferation Cell Line Cell lines Cell physiology Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes Cyclin-dependent kinase inhibitor p21 Deoxyribonucleic acid DNA DNA damage DNA Damage - physiology DNA Repair - physiology Doxorubicin Doxorubicin - toxicity Fibroblasts - drug effects Flow Cytometry Fluorescent Antibody Technique Fundamental and applied biological sciences. Psychology Gene expression Genetics Genomic instability Genomics HeLa Cells Histone H2A Histones - metabolism Humans Immunoprecipitation Mass Spectrometry Mass spectroscopy Mice Mitosis Mitosis - drug effects Mitosis - physiology Molecular and cellular biology Molecular Sequence Data Oncology p53 Protein Poly (ADP-Ribose) Polymerase-1 Poly(ADP-ribose) Poly(ADP-ribose) polymerase Poly(ADP-ribose) Polymerases - metabolism Protein Kinases - genetics Protein Kinases - metabolism Protein-Serine-Threonine Kinases rho GTP-Binding Proteins - metabolism Ribose RNA Interference RNA-mediated interference Rodents Signal Transduction - physiology Spindles Transfection Tumor Suppressor Protein p53 - metabolism Tumorigenesis Tumors Yeast |
Title | BubR1 is involved in regulation of DNA damage responses |
URI | http://dx.doi.org/10.1038/sj.onc.1209392 https://www.ncbi.nlm.nih.gov/pubmed/16449973 https://www.proquest.com/docview/227358081 https://www.proquest.com/docview/2641352520 https://search.proquest.com/docview/20738525 https://search.proquest.com/docview/21330176 |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1da9tATKwp-4AxtqzdsnaZHwZ78urzfT-NNGspg4ZRVsibOZ_voIXZWZwM9u-ni88Jga0vxliydUiWTrrTSQAf84y7ilQ2zT0NR3JylipT0dTb0sugXH5TeP56Jq5u2bc5n8cFtzamVfY2cWOoq8aGNfIznLhJKN2ZZ18Wv9LQNSrsrsYWGgdwmGOkkA3g8Pxi9v1ma4tll3WIfkSWoiuT92UbqTpr7z83qILh7CjV-d60FI3ztrbm84VpkWO-a3Xxf190MyddvoQX0ZlMJp30X8EjVw_hcdde8s8Qnk77bm5DeHIdN9FfgzxflzckuWuTuxqN029X4U2y7JrSo5iSxidfZ5OkMj_R2CBgk0Xr2iO4vbz4Mb1KY_-E1HKhV2kliMmUZ856ww1lgpfairKUmhvlnWSGMIvPCaEoGgxEvNPEOYExmslKr-gxDOqmdm8h4UwYy5yWThlmaaUxisKPVJnPdGktG8Gnnn3FoiuTUWy2t6kq2vsCGV1ERiNm4G4R9Ge1NNbEYwBIJ1SiKiZE6eCUCT6C0z1MZJjdAx938tkR7CmM9-S1g0slKJP45kkvwCJqbFvk6Mfx0IYEyf4Duv37RvBhCw4jCjlqtWvWiJOFykA5fwCDULSnUozgTffb7IaGbqnWkr57mPgJPOuWgERK-CkMVsu1e49O0aocw4GcS7yqKRlHLfgLQBwJYA |
link.rule.ids | 315,783,787,12068,12235,21400,27936,27937,31731,31732,33278,33279,33756,33757,43322,43591,43817,74073,74342,74630 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1db9Mw0IJNMCSEoOyjbGx5QOLJLI6_4ifUjU0F1gpNm7Q3y3FsaZNIStMi8e85J06rSrC3KHfJWXe-8519vkPoQ5ZyV5LS4szTcCUnYzg3JcXeFl4G5fJt4fnJVIxv2bc7fhc33JqYVtnbxNZQl7UNe-SnsHCTULozSz_PfuHQNSqcrsYWGk_RdihVBcHX9tnF9Mf1yhbLLusQ_IgUgyuT9WUbaX7aPHyqQQXD3VGqso1lKRrnVW3NlzPTAMd81-ri_75ouyZdvkavojOZjDrpv0FPXDVAz7r2kn8GaOe87-Y2QM8n8RD9LZJny-KaJPdNcl-BcfrtSnhI5l1TehBTUvvky3SUlOYnGBsAtFm0rtlFt5cXN-djHPsnYMuFWuBSEJPmnjnrDTeUCV4oK4pCKm5y7yQzhFl4TwgF0UAg4p0izgmI0Uxa-Jzuoa2qrtwBSjgTxjKnpMsNs7RUEEXBT8rUp6qwlg3Rx559etaVydDt8TbNdfOggdE6MhowA3d10J_F3FgTrwEAnVCJSo9IroJTJvgQHW1gAsPsBnivk8-aYE_heENea7jMBWUSvjzsBaijxjY6Az-OhzYkQPYf0NXsG6KTFTiMKOSoVa5eAk4aKgNl_BEMQsGeSjFE-920WQ8N3FKlJH33OPETtDO-mVzpq6_T74foRbcdJDDhR2hrMV-69-AgLYrjqAV_AYwACqY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED-2lHWDMbas3bJ2rR8Ge_JiWV_W00g_QvfRUMoKfTOyLEELs7M4Gey_38mWEwJb34xP9ok73ekkne4H8CFNuC1JaeLUUX8lJ2VxpksaO1M46Y3LtYXnL2fi4oZ9veW3If-pCWmVvU9sHXVZG79HPsaJm_jSnWkydiEt4ups-nn-K_YIUv6kNcBpPIYdyQRNBrBzcj67ul77ZdllIGJMkcQY1qR9CUeajZv7TzWao79HSlW6NUUFR72us_l8rhuUnutgL_4fl7bz0_QlvAiBZTTpRsIreGSrITzpoCb_DOHpaY_sNoTdy3Cg_hrkyaq4JtFdE91V6Kh-2xIfokUHUI8qi2oXnc0mUal_ouNBQptRa5s9uJme_zi9iAOWQmy4UMu4FEQnmWPWOM01ZYIXyoiikIrrzFnJNGEG3xNCUU24KHFWEWsFrtd0UriM7sOgqiv7FiLOhDbMKmkzzQwtFa6o8Cdl4hJVGMNG8LEXXz7vSmbk7VE3zfLmPkdB50HQ2NJLN_e2tFxoo8OVAOTjq1LlE5IpH6AJPoLDrZYoMLNF3u_0s2HYczja0teGLjNBmcQvD3oF5sF6mzzFmI57SBJk-w_qeiSO4HhN9j3y-WqVrVfYJvFVglL-QAtC0bdKMYI33bDZdA1DVKUkffcw82PYRQPIv3-ZfTuAZ93OkIgJP4TBcrGy7zFWWhZHwQj-Ajg3DtQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=BubR1+is+involved+in+regulation+of+DNA+damage+responses&rft.jtitle=Oncogene&rft.au=Fang%2C+Y&rft.au=Liu%2C+T&rft.au=Wang%2C+X&rft.au=Yang%2C+Y-M&rft.date=2006-06-15&rft.pub=Nature+Publishing+Group&rft.issn=0950-9232&rft.eissn=1476-5594&rft.volume=25&rft.issue=25&rft.spage=3598&rft_id=info:doi/10.1038%2Fsj.onc.1209392&rft.externalDocID=A189056265 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9232&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9232&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9232&client=summon |